NewsRx

Search our medical news database

Cancer Weekly

Susan Hasty, Publisher

Table of Contents . . . December 21st, 1998

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Weekly | Other Publications

Immunology - Attack on Cancer Soups Up Body's Immune Cells

Kaposi's Sarcoma - Angiogenesis Inhibition Demonstrated in HIV Associated KS Model

Non-Hodgkin's B-Cell Lymphoma - Therapy Combines Radiation with Drug that Targets Tumors

Prostate Cancer (Erectile Function) - Device Helps Preserve Sexual Potency After Cancer Surgery

Prostate Cancer (Therapy) - Acylfulvene Anti-cancer Drug Study Expanded

Small-Cell Lung Cancer (Clinical Trials) - Anti-Angiogenic, Shark Cartilage-Based Therapy Trial Begins

Testing (STDs) - Clinical Trial Data Presented on the Hybrid Capture II Test

Cancer Angiogenesis - "Inflammatory Mast Cells Potentiate the Angiogenic Switch During Squamous Epithelial Carcinogenesis."

Cancer Gene Therapy - "Establishment of a SCID Mouse Model for the Study of Human Cervical Cancer."

Disease Associations - "Bone Loss and Prostate Cancer."

Disease Associations - "Hepatitis C Virus-Associated Malignant Transformation in Liver Produces a Cytotoxic Antimalignin Antibody Immune Response Which Can Be Augmented by a Synthetic Vaccine."

Neoangiogenesis - "Osteoclast Recruitment, Formation, and Bone Resorptive Activity are Increased in Parallel with Neoangiogenesis on the Chick Chorioallantoic Membrane in Response to the Angiogenic Peptides bFGF or IL8."

Treatment Complications - "Body Composition in Men with Prostate Cancer Receiving Different Modalities of Androgen Ablation."

Bladder Cell Carcinoma (Diagnostics) - "Cytokeratin 20: A New Marker for Early Detection of Bladder Cell Carcinoma."

Breast Cancer - "Vascular Integrin alpha(v)beta(3): A New Prognostic Indicator in Breast Cancer."

Cancer Immunotherapy - "Adjuvant Treatment of Breast Cancer: A Pilot Immunochemotherapy Study with CMF, Interleukin-2 and Interferon alpha."

Cancer Immunotherapy - "Pharmacological Administration of Granulocyte/Macrophage-Colony-Stimulating Factor is of Significant Importance for the Induction of a Strong Humoral and Cellular Response in Patients Immunized with Recombinant C

Cancer Immunotherapy (Monoclonal Antibodies) - "An Anti-CD19 Antibody Coupled to a Tetanus Toxin Peptide Induces Efficient Fas Ligand (FasL)-Mediated Cytotoxicity of a Transformed Human B-cell Line by Specific CD4+ ENDSUPER

Melanoma - "Enhancement of Complement-Dependent Cytotoxicity by Polyvalent Melanoma Cell Vaccine (CancerVax): Correlation with Survival."

Ribosomal Immunotherapy - "Economic Evaluation of Ribosomal Immunotherapy in Patients with Chronic Ear, Nose and Throat and Respiratory Tract Infections: Results for Italy."

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook